These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24663083)

  • 1. Endogenous nitric-oxide synthase inhibitor ADMA after acute brain injury.
    Jung CS; Wispel C; Zweckberger K; Beynon C; Hertle D; Sakowitz OW; Unterberg AW
    Int J Mol Sci; 2014 Mar; 15(3):4088-103. PubMed ID: 24663083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric dimethylarginine, an endogenous NOS inhibitor, is actively metabolized in rat erythrocytes.
    Yokoro M; Suzuki M; Murota K; Otsuka C; Yamashita H; Takahashi Y; Tsuji H; Kimoto M
    Biosci Biotechnol Biochem; 2012; 76(7):1334-42. PubMed ID: 22785485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M; Liu L; Guo Z; Xiong Y
    Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
    Stühlinger MC; Conci E; Haubner BJ; Stocker EM; Schwaighofer J; Cooke JP; Tsao PS; Pachinger O; Metzler B
    Cardiovasc Res; 2007 Jul; 75(2):417-25. PubMed ID: 17559823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage.
    Jung CS; Iuliano BA; Harvey-White J; Espey MG; Oldfield EH; Pluta RM
    J Neurosurg; 2004 Nov; 101(5):836-42. PubMed ID: 15543672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
    Zhu ZD; Ye JM; Fu XM; Wang XC; Ye JY; Wu XR; Hua P; Liao YQ; Xuan W; Duan JL; Li WY; Fu H; Xia ZH; Zhang X
    Int J Mol Med; 2019 Feb; 43(2):749-760. PubMed ID: 30569164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
    Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The asymmetric dimethylarginine-mediated inhibition of nitric oxide in the rostral ventrolateral medulla contributes to regulation of blood pressure in hypertensive rats.
    Tan X; Li JK; Sun JC; Jiao PL; Wang YK; Wu ZT; Liu B; Wang WZ
    Nitric Oxide; 2017 Jul; 67():58-67. PubMed ID: 28392446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
    Hu X; Atzler D; Xu X; Zhang P; Guo H; Lu Z; Fassett J; Schwedhelm E; Böger RH; Bache RJ; Chen Y
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH.
    Pluta RM
    Neurol Res; 2006 Oct; 28(7):730-7. PubMed ID: 17164036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
    Millatt LJ; Whitley GS; Li D; Leiper JM; Siragy HM; Carey RM; Johns RA
    Circulation; 2003 Sep; 108(12):1493-8. PubMed ID: 12952847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of the PRMT1-ADMA-DDAH1 metabolism axis and probucol treatment in diabetic patients and diabetic rats.
    Mei X; Zeng J; Liu DF; Zhao Y; Yang HL; Li Y; Qiu P; Tang MW
    Ann Palliat Med; 2021 Mar; 10(3):3343-3353. PubMed ID: 33849119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
    Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
    Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y⁺LAT2 Carrier-Mediated Loss.
    Milewski K; Bogacińska-Karaś M; Fręśko I; Hilgier W; Jaźwiec R; Albrecht J; Zielińska M
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
    Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
    Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
    Maas R
    Vasc Med; 2005 Jul; 10 Suppl 1():S49-57. PubMed ID: 16444869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide synthase inhibitors and cerebral vasospasm.
    Jung CS
    Acta Neurochir Suppl; 2011; 110(Pt 1):87-91. PubMed ID: 21116921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats.
    Sasaki A; Doi S; Mizutani S; Azuma H
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1480-7. PubMed ID: 17322279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endogenous nitric oxide synthase inhibitor in gastric mucosal injury.
    Wang L; Zhou Y; Peng J; Zhang Z; Jiang DJ; Li YJ
    Can J Physiol Pharmacol; 2008 Mar; 86(3):97-104. PubMed ID: 18418436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.